Common Contracts
3 similar null contracts by Jackson Acquisition Co II, Oaktree Acquisition Corp. III Life Sciences, Willow Lane Acquisition Corp.
WILLOW LANE ACQUISITION CORP. Suite 415 New York, NY 10107Willow Lane Acquisition Corp. • October 3rd, 2024 • Blank checks • New York
Willow Lane Acquisition Corp., a Cayman Islands exempted company (the “Company”), is pleased to accept the offer Willow Lane Sponsor, LLC, a Delaware limited liability company, (the “Subscriber” or “you”) has made to subscribe for 4,364,250 Class B ordinary shares of the Company (the “Shares”), $0.0001 par value per share (the “Class B Ordinary Shares”), up to 569,250 of which are subject to complete or partial forfeiture by you if the underwriters of the Company’s initial public offering (“IPO”) of units (“Units”) do not fully exercise their over-allotment option (the “Over-allotment Option”). For the purposes of this Agreement, references to “Ordinary Shares” are to, collectively, the Class B Ordinary Shares and the Company’s Class A ordinary shares, $0.0001 par value per share (the “Class A Ordinary Shares”). Pursuant to the Company’s memorandum and articles of association (as may be amended, the “Articles”), Class B Ordinary Shares will convert into Class A Ordinary Shares on a one
Jackson Acquisition Company II Alpharetta, GA 30009Jackson Acquisition Co II • September 27th, 2024 • Georgia
We are pleased to accept the offer RJ Healthcare SPAC II, LLC (the “Subscriber” or “you”) has made to purchase 5,750,000 Class B ordinary shares (the “Shares”), $0.0001 par value per share (the “Class B Shares”), up to 750,000 Shares of which are subject to complete or partial forfeiture by you if the underwriters of the initial public offering (“IPO”) of Jackson Acquisition Company II, a Cayman Islands exempted company (the “Company”), do not fully exercise their over-allotment option (the “Over-allotment Option”). For the purposes of this Agreement, references to “Ordinary Shares” are to, collectively, the Class B Shares and the Company’s Class A ordinary shares, $0.0001 par value per share (the “Class A Shares”). Pursuant to the Company’s memorandum and articles of association, as amended to the date hereof (the “Articles”), Class B Shares will convert into Class A shares on a one-for-one basis, subject to adjustment, upon the terms and conditions set forth in the Articles. Unless t
Oaktree Acquisition Corp. III Life Sciences c/o Oaktree Capital Management, L.P. Los Angeles, California 90071Oaktree Acquisition Corp. III Life Sciences • September 13th, 2024 • Blank checks • Delaware
This agreement (this "Agreement") is entered into on July 15, 2024 by and between Oaktree Acquisition Holdings III LS, L.P., a Cayman Islands exempted limited partnership (the "Subscriber" or "you"), and Oaktree Acquisition Corp. III Life Sciences, a Cayman Islands exempted company (the "Company"). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to purchase 5,031,250 Class B ordinary shares, $0.0001 par value per share (the "Shares"), up to 656,250 of which are subject to surrender and cancellation by you, as further described in Section 3.1 below, to the extent the underwriters of the initial public offering ("IPO") of Class A ordinary shares, $0.0001 par value per share, of the Company do not fully exercise their over-allotment option (the "Over-allotment Option"). For the purposes of this Agreement, references to “Ordinary Shares” are to, collectively, the Class B ordinary shares, $0.0001 par value per share (the "Class B Ordinary Shares")
